Abstract
Accurate delineation of the gross tumour volume (GTV) in radiation therapy process is mandatory, especially when sophisticated techniques for radiotherapy delivery are used. Functional imaging, particularly PET and its fusion with anatomical modalities, such as PET/CT, promises to improve detection and characterization of disease. Quantitative accuracy in PET imaging is affected by several factors, which influence PET data so as to accurately delineate volume for radiotherapy planning purpose. Several strategies in using PET for target volume definition in radiotherapy treatment planning are being explored in the last years. In the present paper we give an overview of different techniques proposed to generate PET-based tumour volumes and the potential of their use in the radiation oncology process.
Keywords: PET/CT, tumour volume, radiotherapy
Current Radiopharmaceuticals
Title: Use of Positron Emission Tomography for Target Volume Definition
Volume: 2 Issue: 3
Author(s): Federica Fioroni, Elisa Grassi, Roberto Sghedoni, Marco Antonio Sarti, Annibale Versari, Salvo Diana and Gianni Borasi
Affiliation:
Keywords: PET/CT, tumour volume, radiotherapy
Abstract: Accurate delineation of the gross tumour volume (GTV) in radiation therapy process is mandatory, especially when sophisticated techniques for radiotherapy delivery are used. Functional imaging, particularly PET and its fusion with anatomical modalities, such as PET/CT, promises to improve detection and characterization of disease. Quantitative accuracy in PET imaging is affected by several factors, which influence PET data so as to accurately delineate volume for radiotherapy planning purpose. Several strategies in using PET for target volume definition in radiotherapy treatment planning are being explored in the last years. In the present paper we give an overview of different techniques proposed to generate PET-based tumour volumes and the potential of their use in the radiation oncology process.
Export Options
About this article
Cite this article as:
Fioroni Federica, Grassi Elisa, Sghedoni Roberto, Sarti Antonio Marco, Versari Annibale, Diana Salvo and Borasi Gianni, Use of Positron Emission Tomography for Target Volume Definition, Current Radiopharmaceuticals 2009; 2 (3) . https://dx.doi.org/10.2174/1874471010902030144
DOI https://dx.doi.org/10.2174/1874471010902030144 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Current Drug Targets MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets Lesson Learned from Nature for the Development of Novel Anti-Cancer Agents: Implication of Isoflavone, Curcumin, and their Synthetic Analogs
Current Pharmaceutical Design The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Current Cancer Drug Targets Gonioprobe, an Innovative Gamma-probe to Guide Parathyroid Radioguided Surgery: First Clinical Experiences with Navigator and Lock-ontarget Functions
Current Radiopharmaceuticals Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Current Medicinal Chemistry Evaluation on Auto-segmentation of the Clinical Target Volume (CTV) for Graves' Ophthalmopathy (GO) with a Fully Convolutional Network (FCN) on CT Images
Current Medical Imaging Aurora A and B Kinases - Targets of Novel Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Modulation of Mast Cell and Basophil Functions by Benzene Metabolites
Current Pharmaceutical Design Cancer-Targeting Multifunctionalized Gold Nanoparticles in Imaging and Therapy
Current Medicinal Chemistry Protein kinases and the Hypoxia-Inducible Factor-1, two switches in angiogenesis
Current Pharmaceutical Design Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques
Combinatorial Chemistry & High Throughput Screening Radiolabeled RGD Peptides as Integrin alpha(v)beta3–targeted PET Tracers
Current Medicinal Chemistry Nonviral Approach for Targeted Nucleic Acid Delivery
Current Medicinal Chemistry Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology Feasibility of Margin Reduction for Level II and III Planning Target Volume in Head-and-Neck Image-Guided Radiotherapy – Dosimetric Assessment via A Deformable Image Registration Framework
Current Cancer Therapy Reviews Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Current Cancer Drug Targets New Ways to Improve Breast Cancer Therapy Targeting Specific Molecular Pathways
Current Cancer Therapy Reviews PET and SPECT Imaging for the Acceleration of Anti-Cancer Drug Development
Current Drug Targets